Completed
Phase I, Study in Chinese NSCLC Patients
NCT02529995
- Conditions
- Carcinoma, Carcinoma, Non-Small-Cell Lung With EGFR Mutation Positive, Neoplasms, +2 more
- Locations
-
- Research Site Guangzhou, China
- Research Site Shanghai, China